|
|
|
Volumn 64, Issue , 2010, Pages
|
|
How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
PROSTACYCLIN;
DOSE RESPONSE;
EXERCISE TOLERANCE;
HEMODYNAMICS;
HOSPITALIZATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MORTALITY;
PULMONARY HYPERTENSION;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
SURVIVAL;
ANTIHYPERTENSIVE AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EPOPROSTENOL;
EXERCISE TOLERANCE;
HEMODYNAMICS;
HUMANS;
HYPERTENSION, PULMONARY;
INFUSIONS, INTRAVENOUS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SEVERITY OF ILLNESS INDEX;
SURVIVAL ANALYSIS;
|
|
EID: 79952234705
PISSN: 1368504X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (0)
|
